XML 21 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Income Tax Expense
12 Months Ended
Jun. 30, 2025
Statements [Line Items]  
Income Tax Expense
NOTE 6. INCOME TAX EXPENSE
 
    
Consolidated
 
  
June 30, 2025
A$
    
June 30, 2024
A$
    
June 30, 2023
A$
 
Current tax
 
Current tax on profits for the fiscal year
     —         —         —   
  
 
 
    
 
 
    
 
 
 
Total current tax expense
     —         —         —   
  
 
 
    
 
 
    
 
 
 
Deferred income tax
        
Decrease in deferred tax assets
     3,797,425        (1,730,865      (2,326,468
Decrease in deferred tax liabilities
     (3,797,425      1,730,865        2,326,468  
Total deferred tax (benefit)/expense
     —         —         —   
  
 
 
    
 
 
    
 
 
 
Income tax expense
     —         —         —   
  
 
 
    
 
 
    
 
 
 
 
    
Consolidated
 
  
June 30, 2025
A$
    
June 30, 2024
A$
    
June 30, 2023
A$
 
Numerical reconciliation of income tax expense to prima facie tax expense
        
Loss before income tax expense
     (61,434,165      (42,716,625      (39,896,348
Tax at the Australian tax rate of 25% (2024 & 2023:25%)
     (15,358,541      (10,679,156      (9,974,087
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:
        
Non-deductible share-based payments
     290,886        449,072        500,393  
Other non-deductible expenses
     518,807        31,997        332,523  
Non-assessable income
     (1,252,948      (930,697      (828,500
Deductible capital listing fee
     (675,897      (834,683      (507,561
Adjustment of current tax for prior period
     —         —         —   
Difference in overseas tax rates*
     9,520,599        6,542,761        5,442,226  
  
 
 
    
 
 
    
 
 
 
     (6,957,094      (5,420,706      (5,035,006
  
 
 
    
 
 
    
 
 
 
Net adjustment to deferred tax assets and liabilities for tax losses and temporary differences not recognized
     6,957,094        5,420,706        5,035,006  
  
 
 
    
 
 
    
 
 
 
Income tax expense**
  
 
— 
 
  
 
— 
 
  
 
— 
 
  
 
 
    
 
 
    
 
 
 
 
*
Difference in overseas tax rate is largely as a result of the corporate income
tax
rate of 10% applicable to the Immutep subsidiary in France for fiscal year 2025, 2024 and 2023.
**
Income tax expense relates to tax payable for the Immutep subsidiary in the United States.
 
 
    
Consolidated
 
  
June 30, 2025
A$
    
June 30, 2024
A$
    
June 30, 2023
A$
 
Deferred tax assets for tax losses not recognized comprises:
        
Unused tax losses for which no deferred tax asset has been recognized
     399,133,050        310,330,626        221,070,595  
  
 
 
    
 
 
    
 
 
 
Total deferred tax assets for tax losses not recognized
  
 
61,624,110
 
  
 
58,586,607
 
  
 
42,042,046
 
  
 
 
    
 
 
    
 
 
 
The above potential tax benefit for tax losses has not been recognized in the consolidated balance sheet as the recovery of this benefit is not probable. There is no expiration date for the tax losses carried forward. The estimated amount of cumulative tax losses at June 30, 2025 was $399,133,050 (2024: $310,330,626, 2023: 221,070,595). Utilization of these tax losses is dependent on the parent entity and its subsidiaries satisfying certain tests at the time the losses are recouped and in generating future taxable profits against which to utilize the losses.